Active soluble post-translationally modified neuregulin...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2705328

The present invention refers to soluble Neuregulin-1 isoforms representing Posttranslational Neuregulin-1 modifi-cations as medication in cognition- related neurological disorders, in particular schizophrenia, Alzheimer's and Parkinson's diseases.

La présente invention porte sur des isoformes solubes de neuréguline-1, représentant des modifications de la neuréguline-1 post-traductionnelle en tant que médication dans des troubles neurologiques apparentés à la cognition, en particulier la schizophrénie, la maladie d'Alzheimer et la maladie de Parkinson.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Active soluble post-translationally modified neuregulin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Active soluble post-translationally modified neuregulin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active soluble post-translationally modified neuregulin... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1956854

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.